RELATION

Serial Number 79381308
Registration 7674099
700

Registration Progress

Application Filed
Sep 14, 2023
Under Examination
Approved for Publication
Dec 17, 2024
Published for Opposition
Dec 17, 2024
Registered
Feb 4, 2025

Trademark Image

RELATION

Basic Information

Serial Number
79381308
Registration Number
7674099
Filing Date
September 14, 2023
Registration Date
February 4, 2025
Published for Opposition
December 17, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 4, 2025
Registration
Registered
Classes
005 009 042

Rights Holder

Relation Therapeutics Limited

24
Address
Floor 7,338 Euston Road
London NW1 3BG
GB

Ownership History

Relation Therapeutics Limited

Original Applicant
24
GB

Relation Therapeutics Limited

Owner at Publication
24
GB

Relation Therapeutics Limited

Original Registrant
24
GB

Legal Representation

Attorney
David E. Weslow

USPTO Deadlines

Next Deadline
2030 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-04)
Due Date
February 04, 2031
Grace Period Ends
August 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
Feb 4, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 4, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 17, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 17, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 11, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 18, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 28, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 28, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 28, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 11, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
May 23, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 23, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 14, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 13, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 31, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 19, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceuticals and medical preparations for the treatment of bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic disease
Class 009
Downloadable computer software for development of treatments for bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic disease; Downloadable science software for analyzing scientific research data and managing research studies; Downloadable bioinformatics computer software for analyzing bioinformatics data and managing research studies; Downloadable computer software using artificial intelligence (AI) for development of treatments for bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic disease; Electronic downloadable publications in the nature of articles, books and reports in the field of bone disease, immunology, neuroscience, dermatological disorders and metabolic disease
Class 042
Scientific research relating to biology; testing of pharmaceuticals; pharmaceutical products development; research of pharmaceuticals; drug discovery and development services; software-as-a-service (SAAS) services featuring software for development of treatments for bone disease, diseases and disorders of the immune system, neurological diseases and disorders, dermatological disorders and metabolic disease; technical data analysis services for scientific research purposes; medical laboratory services; scientific, medical and pharmaceutical research and development services; information, advisory and consultancy services in relation to the aforesaid.

Classification

International Classes
005 009 042